[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology), By Application, By End Use, By Region, And Segment Forecasts, 2022 - 2030

October 2022 | 150 pages | ID: P456703A4E18EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 2 Business Days

Proteinase K Market Growth & Trends

The global proteinase K market size is expected to reach USD 7.84 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.84% from 2022 to 2030. The market growth is fueled by a broad range of applications in molecular diagnostic techniques and their associated enzymes for IVD. Proteinase K can be utilized as a supplement in PCR and NGS. Increasing applications of NGS in personalized medicine along with various clinically developed therapies are likely to favor the market for proteinase K. Gene expression profiling and targeted panels via qPCR remain the two most frequent uses for NGS sequences in a pathology lab. In addition, a decline in the price of NGS sequencing has expanded the use of NSC technologies. Therefore, the growing demand for NGS diagnostic techniques is expected to boost the market growth.

In addition, the rising adoption of cell separation procedures is one of the major factors contributing to the market growth. Companies have initiated building sustainable technologies to gain a competitive edge in the market. For instance, in April 2022, Levitas Bio introduced the next generation of its existing platform for cell separation. The new version is expected to assist researchers in scaling their experiments up to 16X and process around 40 million cells per run.

Moreover, the usage of POC-based diagnostics is increasing significantly globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling disease transmission. Thus, increased patient attention has led to a rise in demand for POC. For instance, in May 2020, a study on POC testing for COVID-19 through Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) diagnostics was published. The researchers used QuickExtract by Lucigen, which contains Proteinase K. Thus, the growing demand for POC diagnostics and the utility of proteinase K in POC diagnostic tests are expected to fuel market growth.

Furthermore, growing applications of proteinase K in molecular biology and other fields are expected to create lucrative opportunities in the near future. Proteinase K is used in the food and beverage industry to maintain quality standards. Food manufacturers work to maintain the quality of raw materials used for manufacturing. In addition, proteinase K is used for cell lysis during DNA extraction from processed foods. The enzyme also finds application in a wide range of molecular biology assays. Hence, such applications of proteinase K are anticipated to drive the market during the forecast period.

Proteinase K Market Report Highlights
  • By form, the powder segment accounted for a dominant share in 2021. Advantages of powder form include long shelf-life, inexpensive shipment, and high stability. Thus, such advantages are expected to increase the adoption of powder
  • By therapeutic area, the infectious diseases segment captured the largest share in 2021. Presence of proteinase K in the rapid molecule testing along with increasing incidence of infectious diseases in low- to mid-income countries is anticipated to encourage players to develop products that are easy to operate in a low-resource setting. This is, in turn, accelerating the market growth
  • By application, the isolation and purification of genomic DNA and RNA segment held the largest share in 2021. With the emerging need for personalized treatment in cancer and rare diseases, the demand for DNA or RNA isolation is anticipated to witness upward trends and similar trends will be reflected in the market
  • By end-use, biotechnology companies held a leading revenue share in 2021. This is due to an increase in the application of In Situ Hybridization (ISH) techniques to support clinical and preclinical studies for biotechnology companies
  • North America occupied the largest market share in 2021 and is expected to maintain its lead over the forecast period owing to the high demand for proteinase K and the increasing prevalence of infectious diseases in the region
  • Asia Pacific is projected to grow considerably in the future owing to increasing applications of sequencing technology, coupled with various government initiatives to promote genomics research
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
    1.3.1.1 Secondary Data Sources
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Global Market: CAGR Calculation
1.7 Objectives
  1.7.1 Objective
  1.7.2 Objective

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook
2.2 Segment Outlook
2.3 Market Segmentation

CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Lineage Outlook
  3.1.1 Parent Market Analysis
    3.1.1.1 Ivd Market
    3.1.1.2 Molecular Biology Enzymes And Kits Market
  3.1.2 Related/Ancillary Market Outlook
3.2 Impact of COVID-19 Pandemic on Proteinase K Market
3.3 Penetration & Growth Prospect Mapping
3.4 Proteinase K Market Dynamics
  3.4.1 Market Driver Analysis
    3.4.1.1 Broad Applications Of Molecular Diagnostic Techniques And Their Associated Enzymes For Ivd
    3.4.1.2 Rise In Demand For Poc Diagnostics And Utility Of Proteinase K In Poc Diagnostic Tests
    3.4.1.3 Increasing Adoption Of Cell Separation Technique
  3.4.2 Market Restraint Analysis
    3.4.2.1 Reimbursement Challenges Associated With Diagnostic Tests
  3.4.3 Market Opportunity Analysis
    3.4.3.1 Applications Of Proteinase K In Molecular Biology And Other Fields
  3.4.4 Market Challenge Analysis
    3.4.4.1 Challenges Associated With Purification & Recovery Of Enzymes
3.5 Proteinase K Market Industry Analysis
  3.5.1 Porter’s
  3.5.2 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 Major Deals & Strategic Alliances Analysis
  3.6.1 Joint Ventures
  3.6.2 Mergers & Acquisitions
  3.6.3 Licensing & Partnership
  3.6.4 Technology Collaborations
  3.6.5 Strategic Divestments

CHAPTER 4 FORM BUSINESS ANALYSIS

4.1 Form Movement Analysis & Market Share, 2021 & 2030
4.2 Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.3 Powder
  4.3.1 Global proteinase K market for powder form, 2018 - 2030 (USD Million)
4.4 Liquid
  4.4.1 Global proteinase K market for liquid form, 2018 - 2030 (USD Million)

CHAPTER 5 THERAPEUTIC AREA BUSINESS ANALYSIS

5.1 Therapeutic Area Movement Analysis & Market Share, 2021 & 2030
5.2 Infectious diseases
  5.2.1 Global proteinase K market for infectious diseases, 2018 - 2030 (USD Million)
5.3 Diabetes
  5.3.1 Global proteinase K market for diabetes, 2018 - 2030 (USD Million)
5.4 Oncology
  5.4.1 Global proteinase K market for oncology, 2018 - 2030 (USD Million)
5.5 Cardiology
  5.5.1 Global proteinase K market for cardiology, 2018 - 2030 (USD Million)
5.6 Nephrology
  5.6.1 Global proteinase K market for nephrology, 2018 - 2030 (USD Million)
5.7 Autoimmune Diseases
  5.7.1 Global proteinase K market for autoimmune diseases, 2018 - 2030 (USD Million)
5.8 Neurology
  5.8.1 Global proteinase K market for neurology, 2018 - 2030 (USD Million)
5.9 Others
  5.9.1 Global proteinase K market for others, 2018 - 2030 (USD Million)

CHAPTER 6 APPLICATION BUSINESS ANALYSIS

6.1 Application Movement Analysis & Market Share, 2021 & 2030
6.2 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3 Isolation and Purification of Genomic DNA & RNA
  6.3.1 Global proteinase K market for isolation and purification of genomic DNA & RNA, 2018 - 2030 (USD Million)
6.4 In Situ Hybridization
  6.4.1 Global proteinase K market for ISH market, 2018 - 2030 (USD Million)
6.5 Mitochondria isolation
  6.5.1 Global proteinase K market for mitochondria isolation market, 2018 - 2030 (USD Million)

CHAPTER 7 END-USE BUSINESS ANALYSIS

7.1 End-Use Movement Analysis and Market Share, 2021 & 2030
  7.1.1 Biotechnology Companies
    7.1.1.1 Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.1.2 Diagnostic Laboratories
    7.1.2.1 Diagnostic Laboratories Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  7.1.3 Cros
    7.1.3.1 Cros Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.1.4 Academic Institutes
    7.1.4.1 Academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)

CHAPTER 8 REGIONAL BUSINESS ANALYSIS

8.1 Proteinase K Market Share by Regional, 2021 & 2030
8.2 North America
  8.2.1 North America Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
  8.2.2 U.S.
    8.2.2.1 U.S. Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.2.3 Canada
    8.2.3.1 Canada Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.3 Europe
  8.3.1 Europe Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
  8.3.2 Germany
    8.3.2.1 Germany Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.3.3 U.K.
    8.3.3.1 U.K. Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.3.4 France
    8.3.4.1 France Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.3.5 Italy
    8.3.5.1 Italy Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.3.6 Spain
    8.3.6.1 Spain Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
  8.4.1 Asia Pacific Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
  8.4.2 Japan
    8.4.2.1 Japan Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.4.3 China
    8.4.3.1 China Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.4.4 India
    8.4.4.1 India Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.4.5 Australia
    8.4.5.1 Australia Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.4.6 Singapore
    8.4.6.1 Singapore Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.5 Latin America
  8.5.1 Latin America Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
  8.5.2 Brazil
    8.5.2.1 Brazil Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.5.3 Mexico
    8.5.3.1 Mexico Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.5.4 Argentina
    8.5.4.1 Argentina Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East and Africa (MEA)
  8.6.1 Mea Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)
  8.6.2 South Africa
    8.6.2.1 South Africa Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.6.3 Saudi Arabia
    8.6.3.1 Saudi Arabia Proteinase K market estimates and forecast, 2018 - 2030 (USD Million)
  8.6.4 UAE
    8.6.4.1 UAE Proteinase K Market Estimates And Forecast, 2018 - 2030 (USD Million)

CHAPTER 9 COMPETITIVE ANALYSIS

9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.2 Company Market Share, 2021
9.3 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
9.4 Vendor Landscape
  9.4.1 Public Companies
  9.4.2 Private Companies

CHAPTER 10 COMPETITIVE LANDSCAPE

  10.1.1 MERCK KGAA
    10.1.1.1 Company Overview
    10.1.1.2 Sigma-Aldrich Co. LLC
      10.1.1.2.1 Company Overview
    10.1.1.3 Financial Performance
    10.1.1.4 Product Benchmarking
    10.1.1.5 Strategic Initiatives
  10.1.2 QIAGEN
    10.1.2.1 Company Overview
    10.1.2.2 Financial Performance
    10.1.2.3 Product Benchmarking
    10.1.2.4 Strategic Initiatives
  10.1.3 THERMO FISHER SCIENTIFIC, INC.
    10.1.3.1 Company Overview
    10.1.3.2 Financial Performance
    10.1.3.3 Product Benchmarking
    10.1.3.4 Strategic Initiatives
  10.1.4 F. HOFFMANN-LA ROCHE LTD.
    10.1.4.1 Company Overview
    10.1.4.2 Financial Performance
    10.1.4.3 Product Benchmarking
    10.1.4.4 Strategic Initiatives
  10.1.5 ABCAM PLC
    10.1.5.1 Company Overview
    10.1.5.2 Financial Performance
    10.1.5.3 Product Benchmarking
    10.1.5.4 Strategic Initiatives
  10.1.6 AGILENT TECHNOLOGIES, INC.
    10.1.6.1 Company overview
    10.1.6.2 Financial performance
    10.1.6.3 Product Benchmarking
    10.1.6.4 Strategic Initiatives
  10.1.7 BIOCATALYSTS LTD.
    10.1.7.1 Company Overview
    10.1.7.2 Financial Performance
    10.1.7.3 Product Benchmarking
    10.1.7.4 Strategic Initiatives
  10.1.8 MINERVA BIOLABS GMBH
    10.1.8.1 Company Overview
    10.1.8.2 Product Benchmarking
    10.1.8.3 Strategic Initiatives
  10.1.9 PROMEGA CORPORATION
    10.1.9.1 Company Overview
    10.1.9.2 Financial Performance
    10.1.9.3 Product Benchmarking
    10.1.9.4 Strategic Initiatives
  10.1.10 TAKARA BIO, INC.
    10.1.10.1 Company Overview
    10.1.10.2 Financial Performance
    10.1.10.3 Product Benchmarking
    10.1.10.4 Strategic Initiatives
  10.1.11 NEW ENGLAND BIOLABS
    10.1.11.1 Company Overview
    10.1.11.2 Product Benchmarking
    10.1.11.3 Strategic Initiatives
  10.1.12 MP BIOMEDICALS
    10.1.12.1 Company Overview
    10.1.12.2 Product Benchmarking
    10.1.12.3 Strategic Initiatives
LIST OF TABLES

Table. 1 List of Secondary Sources
Table. 2 List of Abbreviations
Table. 3 Global Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 4 Global Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 5 Global Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 6 Global Proteinase K Market, by End-use, 2018 - 2030 (USD Million)
Table. 7 Global Proteinase K Market, by Region, 2018 - 2030 (USD Million)
Table. 8 North America Proteinase K Market, by Country, 2018 - 2030 (USD Million)
Table. 9 North America Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 10 North America Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 11 North America Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 12 North America Proteinase K Market, by End-use, 2018 - 2030 (USD Million)
Table. 13 U.S. Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 14 U.S. Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 15 U.S. Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 16 U.S. Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 17 Canada Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 18 Canada Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 19 Canada Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 20 Canada Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 21 Europe Proteinase K Market, by Country, 2018 - 2030 (USD Million)
Table. 22 Europe Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 23 Europe Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 24 Europe Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 25 Europe Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 26 Germany Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 27 Germany Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 28 Germany Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 29 Germany Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 30 U.K. Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 31 U.K. Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 32 U.K. Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 33 U.K. Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 34 France Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 35 France Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 36 France Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 37 France Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 38 Italy Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 39 Italy Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 40 Italy Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 41 Italy Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 42 Spain Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 43 Spain Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 44 Spain Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 45 Spain Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 46 Asia Pacific Proteinase K Market, by Country, 2018 - 2030 (USD Million)
Table. 47 Asia Pacific Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 48 Asia Pacific Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 49 Asia Pacific Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 50 Asia Pacific Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 51 China Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 52 China Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 53 China Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 54 China Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 55 Japan Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 56 Japan Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 57 Japan Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 58 Japan Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 59 India Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 60 India Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 61 India Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 62 India Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 63 Singapore Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 64 Singapore Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 65 Singapore Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 66 Singapore Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 67 Australia Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 68 Australia Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 69 Australia Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 70 Australia Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 71 Latin America Proteinase K Market, by Country, 2018 - 2030 (USD Million)
Table. 72 Latin America Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 73 Latin America Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 74 Latin America Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 75 Latin America Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 76 Brazil Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 77 Brazil Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 78 Brazil Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 79 Brazil Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 80 Mexico Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 81 Mexico Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 82 Mexico Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 83 Mexico Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 84 Argentina Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 85 Argentina Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 86 Argentina Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 87 Argentina Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 88 Middle East & Africa Proteinase K Market, by Country, 2018 - 2030 (USD Million)
Table. 89 Middle East & Africa Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 90 Middle East & Africa Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 91 Middle East & Africa Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 92 Middle East & Africa Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 93 South Africa Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 94 South Africa Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 95 South Africa Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 96 South Africa Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 97 Saudi Arabia Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 98 Saudi Arabia Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 99 Saudi Arabia Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 100 Saudi Arabia Proteinase K Market, End-use, 2018 - 2030 (USD Million)
Table. 101 UAE Proteinase K Market, by Form, 2018 - 2030 (USD Million)
Table. 102 UAE Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table. 103 UAE Proteinase K Market, by Application, 2018 - 2030 (USD Million)
Table. 104 UAE Proteinase K Market, End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Proteinase K Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 16 Global Proteinase K Market: Form Movement Analysis
Fig. 17 Global Proteinase K Market, for Powder, 2018 - 2030 (USD Million)
Fig. 18 Global Proteinase K Market, for Liquid, 2018 - 2030 (USD Million)
Fig. 19 Global Proteinase K Market: Therapeutic Area Movement Analysis
Fig. 20 Global Proteinase K Market, for Infectious diseases, 2018 - 2030 (USD Million)
Fig. 21 Global Proteinase K Market, for Diabetes, 2018 - 2030 (USD Million)
Fig. 22 Global Proteinase K Market, for Oncology, 2018 - 2030 (USD Million)
Fig. 23 Global Proteinase K Market, for Cardiology, 2018 - 2030 (USD Million)
Fig. 24 Global Proteinase K Market, for Nephrology, 2018 - 2030 (USD Million)
Fig. 25 Global Proteinase K Market, for Autoimmune diseases, 2018 - 2030 (USD Million)
Fig. 26 Global Proteinase K Market, for Neurology, 2018 - 2030 (USD Million)
Fig. 27 Global Proteinase K Market, for Others, 2018 - 2030 (USD Million)
Fig. 28 Global Proteinase K Market: Application Movement Analysis
Fig. 29 Global Proteinase K Market, for Isolation and Purification of Genomic DNA & RNA, 2018 - 2030 (USD Million)
Fig. 30 Global Proteinase K Market, for In Situ Hybridization, 2018 - 2030 (USD Million)
Fig. 31 Global Proteinase K Market, for Mitochondria isolation, 2018 - 2030 (USD Million)
Fig. 32 Global Proteinase K Market: End-use Movement Analysis
Fig. 33 Global Proteinase K Market, for Contract Research Organization, 2018 - 2030 (USD Million)
Fig. 34 Global Proteinase K Market, for Academic Institutes, 2018 - 2030 (USD Million)
Fig. 35 Global Proteinase K Market, for Biotechnology Companies, 2018 - 2030 (USD Million)
Fig. 36 Global Proteinase K Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
Fig. 37 Regional Marketplace: Key Takeaways
Fig. 38 Regional Outlook, 2021 & 2030
Fig. 39 Global Biochips Market: Regional Movement Analysis
Fig. 40 North America Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 41 U.S. Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 42 Canada Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 43 Europe Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 44 Germany Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 45 U.K. Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 46 France Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 47 Italy Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 48 Spain Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 50 Japan Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 51 China Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 52 India Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 53 Singapore Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 54 Australia Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 55 Latin America Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 56 Brazil Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 57 Mexico Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 58 Argentina Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 60 South Africa Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia Proteinase K Market, 2018 - 2030 (USD Million)
Fig. 62 UAE Proteinase K Market, 2018 - 2030 (USD Million)


More Publications